JAYME SERVIA: Open Payments
NPI 1457179301 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 33 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $223 |
| Alkermes, Inc. | 3 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Indivior Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Corium, LLC | 3 | $11 |
Products named: MAVYRET, VRAYLAR, COBENFY, FANAPT, REXULTI, ARISTADA, LYBALVI, SUBLOCADE.
Industry payments across WI — which companies pay providers there.
